Keyphrases
Endothelial Function
100%
Nebivolol
100%
Essential Hypertension
100%
Crossover Design
100%
Randomized Double-blind Study
100%
Atenolol
55%
Acetylcholine
22%
Endothelium-dependent
22%
Endothelium-independent
22%
Endothelial Dysfunction
22%
Forearm Blood Flow
22%
Sodium Nitroprusside
22%
Nitric Oxide Release
22%
L-NMMA
22%
Forearm
11%
Hypertension
11%
Low Blood Pressure
11%
Treatment Duration
11%
Beta-blockers
11%
Venous Occlusion Plethysmography
11%
Nitric Oxide
11%
Independent Pathway
11%
Arginine
11%
Hypertensive Patients
11%
Antihypertensive Drugs
11%
Endothelial Nitric Oxide
11%
Vascular Protection
11%
Placebo Run-in
11%
Bioactivity
11%
Intra-arterial Infusion
11%
Blood Pressure Control
11%
Ambulatory Blood Pressure
11%
Patients with Hypertension
11%
Vasodilator Responses
11%
Clinic Blood Pressure
11%
Vascular Endothelial Dysfunction
11%
Pharmacology, Toxicology and Pharmaceutical Science
Essential Hypertension
100%
Nebivolol
100%
Bendroflumethiazide
88%
Atenolol
55%
Endothelial Dysfunction
33%
Nitric Oxide
33%
Nitroprusside Sodium
22%
Acetylcholine
22%
N(g) Methylarginine
22%
Antihypertensive Agent
11%
Atherosclerosis
11%
Placebo
11%
Vein Occlusion
11%
Arginine
11%
Hypotension
11%
Scanning Electron Microscopy
11%
Neuroscience
Nebivolol
100%
Hypertension
100%
Bendroflumethiazide
88%
Atenolol
55%
Nitric Oxide
33%
Acetylcholine
22%
N(g) Methylarginine
22%
Sodium Nitroprusside
22%
Placebo
11%
Arginine
11%
Scanning Electron Microscopy
11%
Antihypertensive Agent
11%